Hansen H, Shahidi A, Stein Z A
Public Health Rep. 1978 May-Jun;93(3):246-51.
In New York City from 1966 to 1970, almost all 736,469 newborns were screened for phenylketonuria (PKU). Among 1,094 infants with presumptive positive test results, 763 were followed up and 46 of them were judged to require preventive treatment. The considerable annual variation observed in the frequency of values of 4 to 6 mg/100 ml bood phenylalanine suggested low reliability at this level. Screening test results of 4 mg/100 ml, with no cases detected among them, represented 53% of all false positive results; newborns with 6 mg/100 ml results yielded 1 infant in need of treatment and accounted for 40% of the false positive results. The large volume of presumptive positive results generated by these levels presumably contributed to incomplete followup. If the threshold value for followup were raised, the effectiveness and the efficiency of the screening program could be improved. The experiences of other large PKU programs in the United States support these observations.
1966年至1970年期间,在纽约市,几乎对所有736,469名新生儿进行了苯丙酮尿症(PKU)筛查。在1,094名筛查结果初步呈阳性的婴儿中,763名接受了随访,其中46名被判定需要进行预防性治疗。观察到血液苯丙氨酸值为4至6毫克/100毫升时,每年的频率变化相当大,表明在此水平上可靠性较低。筛查结果为4毫克/100毫升的情况中未检测到病例,占所有假阳性结果的53%;筛查结果为6毫克/100毫升的新生儿中有1名需要治疗,占假阳性结果的40%。这些水平产生的大量初步阳性结果可能导致随访不完整。如果提高随访的阈值,筛查计划的有效性和效率可能会提高。美国其他大型苯丙酮尿症筛查计划的经验也支持这些观察结果。